TBPH
Theravance Biopharma, Inc. · Health Care · NASDAQ
52-week range
$10.44 – $21.03
Theravance Biopharma, Inc. (TBPH) is held by 0 tracked hedge fund(s) and traded by 1 member(s) of Congress. Sector: Health Care.
No tracked funds currently hold this stock.
No tracked funds currently hold this stock.
No recent hedge-fund trades on this stock.
Recent hedge fund trades
No recent hedge-fund trades on this stock.
Insider trades open-market, past year
No reported open-market insider trades in the past year.
Open-market Form 4 transactions (grants & option exercises excluded). Live from SEC filings.
Congress buys & sells disclosed trades
Price chart
Financials
Symbol info, price chart & financials are live from TradingView (real data — no processing).
📊
Deep Dive — full fundamental analysis
An analyst-grade breakdown of TBPH: the bull & bear thesis, valuation model, segment detail and risks — written from SEC filings.
- Bull & bear case, with conviction score
- Owner-earnings & valuation model
- Segment & geographic revenue breakdown
- Key risks & what would break the thesis
- Peer comparison (vs sector)
🔒 Unlock with WealthFile Pro
⚡
Daily Moves — what's moving TBPH today
A daily, plain-English read on the day's price action and the smart-money & news catalysts behind it.
- Today's price drivers, explained
- Smart-money flow alerts (fund / insider / Congress)
- News & SEC-filing catalysts
- Unusual options activity
🔒 Unlock with WealthFile Pro
Related ▾
FAQ ▾
How much smart money owns TBPH?
0 tracked hedge fund(s) and 1 member(s) of Congress have disclosed positions.
Are members of Congress trading TBPH?
Yes — 1 member(s) have disclosed TBPH trades. See the Congress tab.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.